The risk from zoonotic diseases is fueling the market for Japan veterinary healthcare. Inter-Governmental Organizations and food production are making reforms to ensure health by the process of surveillance and vaccination, investing in R&D, and transfer with respect to vet health. Additionally, advanced technology leading to innovations in animal healthcare, increase in ownership of pet animals and increasing awareness about the health of animals consumed as food are also the factors responsible for the growth of Japan veterinary healthcare market. In 2017, there were 8.92 million pet dogs and 9.52 pet cats in Japan, according to data from the Japan Pet Food Association. However, increasing costs of animal testing and veterinary services, lack of infrastructure and funding and use of counterfeit medicines are restraining the growth of Japan veterinary healthcare market.

Key Market Trends

Molecular Diagnostics holds the major share in Japan Veterinary Healthcare Market

Molecular diagnostics refers to the class of tests performed on an animal, which can assess its health, literally, at the molecular level. It identifies the specific sequence in genes, DNA, RNA, and proteins. It also provides insights on whether the animal has a disease or will have a disease in the future, etc. In Japan, the academic activity in veterinary sciences is showing excellent response to molecular diagnostic methods. The department of veterinary medical sciences at the Graduate School of Agricultural & Life Sciences, University of Tokyo, is involved in conducting advanced molecular, cellular and in vivo levels, in order to fully understand vital processes of normal and diseased animals. Currently, in Japan, three nucleic-acid-based assays, viz., reverse transcription-polymerase chain reaction (RT-PCR), reverse transcription loop-mediated isothermal amplification (RT-LAMP), and real-time RT-PCR, have been developed for detection of Japanese encephalitis virus.

Competitive Landscape

The market for Japan Veterinary Healthcare is majorly dominated by the few players. However, there are few companies that are penetrating the market currently and are expected to hold a substantial share in the market. Major players of the market are Zoetis Inc., Virbac, DS Pharma Animal Health Co., Carus Animal Health Ltd, Nisseiken Co., Ltd., Sumitomo Corporation, Bayer Holding Ltd, NIHON NOHYAKU CO., LTD., NIPPON ZENYAKU KOGYO CO., LTD. Unicharm Corporation amongst others

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support